TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34244284

Group type: EXPERIMENTAL
Intervention: Mechanical and oral antibiotic bowel preparation (MOABP) - 1g neomycin and 1g metronidazole two times on the day prior to surgery
Number of subjects: 604

Group type: COMPARATOR
Intervention: Mechanical bowel preparation (MBP) - identical placebo
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Mechanical and oral antibiotic bowel preparation (MOABP)
Number of subjects: 604

Group type: COMPARATOR
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 604
Study: 33159526

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180-mg loading dose on day 1 followed by 90 mg twice daily for days 2-30) plus aspirin (300 to 325 mg on day 1 followed by 75 to 100 mg daily for days 2 to 30)
Number of subjects: 11016

Group type: COMPARATOR
Intervention: Placebo plus aspirin (300 to 325 mg on day 1 followed by 75 to 100 mg daily for days 2 to 30)
Number of subjects: 11016

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180-mg loading dose on day 1 followed by 90 mg twice daily for days 2-30) plus aspirin
Number of subjects: 11016

Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 11016

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 11016
Study: 35510948

Group type: EXPERIMENTAL
Intervention: Test formulation (single 20 mg dose)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 32
Study: 34811370

Group type: EXPERIMENTAL
Intervention: H56:IC31 vaccination
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Etoricoxib + H56:IC31
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 35654684

Group type: EXPERIMENTAL
Intervention: Vasopressin injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34145906

Group type: EXPERIMENTAL
Intervention: Transitional care interventions (care continuity and coordination, medication management, symptom recognition, self-management)
Number of subjects: 44
Study: 32198304

Group type: EXPERIMENTAL
Intervention: 8-week mindfulness course followed by a 4-month maintenance phase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Text-based information about mindfulness (control group)
Number of subjects: 0
Study: 35840157

Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) 50 mg once weekly
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: SASDAS
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: ASDAS
Number of subjects: 215
Study: 34529026

Group type: EXPERIMENTAL
Intervention: Weekly health education via WeChat
Number of subjects: 1525

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1525
Study: 35881649

Group type: EXPERIMENTAL
Intervention: HITSystem 2.1 eHealth intervention plus standard-of-care PMTCT services
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard-of-care PMTCT services
Number of subjects: 12
Study: 34473451

Group type: EXPERIMENTAL
Intervention: Telephone follow-ups combined with a smartphone app (WeChat)
Number of subjects: 110
Study: 34029149

Group type: EXPERIMENTAL
Intervention: Cetuximab plus Cisplatin
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cetuximab plus Cisplatin plus Paclitaxel
Number of subjects: 300
Study: 32919110

Group type: EXPERIMENTAL
Intervention: Vitamin D3 10 μg/day
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: Vitamin D3 30 μg/day
Number of subjects: 594
Study: 36128557

Group type: EXPERIMENTAL
Intervention: Trusilk ®
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Mersilk ®
Number of subjects: 129
Study: 34041789

Group type: EXPERIMENTAL
Intervention: Heparinoid-containing product for 2 weeks (group A, n=36)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Heparinoid-containing product for 8 weeks (group B, n=35)
Number of subjects: 71
Study: 32057576

Group type: EXPERIMENTAL
Intervention: MVA‐BN‐RSV high dose (1 × 10^8 TCID50)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: MVA‐BN‐RSV low dose (1 × 10^7 TCID50)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: MVA‐BN‐RSV (both doses)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: MVA‐BN‐RSV combined high dose groups
Number of subjects: 63
Study: 35668121

Group type: EXPERIMENTAL
Intervention: Wheat bread enriched with α‐cyclodextrin (α‐CDB)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Wheat bread enriched with hydroxytyrosol/α‐cyclodextrin complex ((HT + α‐CD)B)
Number of subjects: 10

Group type: COMPARATOR
Intervention: White wheat bread (WB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Glucose solution (reference food, GS)
Number of subjects: 10
Study: 34620123

Group type: EXPERIMENTAL
Intervention: Oral carbohydrate-rich (Ch-R) supplement taken 2 hours before elective caesarean delivery
Number of subjects: 88

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 88
Study: 35684118

Group type: EXPERIMENTAL
Intervention: Cystine and theanine (CT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 32478806

Group type: EXPERIMENTAL
Intervention: Cycled phototherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34477469

Group type: EXPERIMENTAL
Intervention: Betaine (BET) supplementation 2.4 g/day for 2 weeks
Number of subjects: 23
Study: 33150572

Group type: EXPERIMENTAL
Intervention: NMES + HPRO
Number of subjects: 25

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 25
Study: 34600848

Group type: COMPARATOR
Intervention: Standard preoperative antibiotics
Number of subjects: 2803

Group type: EXPERIMENTAL
Intervention: Procedural factors (non-modifiable and modifiable)
Number of subjects: 2803

Group type: EXPERIMENTAL
Intervention: Chlorhexidine skin preparation and antibiotic pocket wash
Number of subjects: 2803
Study: 34236435

Group type: EXPERIMENTAL
Intervention: Zinc before breakfast (ZBB) - 25 mg zinc as zinc gluconate taken in the fasted state 30 min before breakfast
Number of subjects: 35

Group type: COMPARATOR
Intervention: Zinc with breakfast (ZWB) - 25 mg zinc as zinc gluconate taken with breakfast
Number of subjects: 35
Study: 32809261

Group type: EXPERIMENTAL
Intervention: Sacubitril‐valsartan
Number of subjects: 8399

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8399

Group type: EXPERIMENTAL
Intervention: Potassium levels (hypokalaemia and hyperkalaemia)
Number of subjects: 8399

Group type: EXPERIMENTAL
Intervention: Potassium abnormalities
Number of subjects: 8399
Study: 35851028

Group type: EXPERIMENTAL
Intervention: Robotic-assisted surgery
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional laparoscopic surgery
Number of subjects: 70
Study: 33821322

Group type: EXPERIMENTAL
Intervention: Filtek BF (FBF; 3M ESPE)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Tetric EvoCeram BF (TBF; Ivoclar Vivadent)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control Filtek Z250 (Z250; 3M ESPE)
Number of subjects: 138
Study: 32758296

Group type: EXPERIMENTAL
Intervention: Bleaching treatment with hydrogen peroxide 35% applied for 2 days (2×1 d)
Number of subjects: 120

Group type: COMPARATOR
Intervention: No bleaching treatment (control group)
Number of subjects: 120
Study: 35899811

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01 vaccine (three doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no vaccine)
Number of subjects: 0
Study: 32491924

Group type: EXPERIMENTAL
Intervention: Wearable Resistance (WR) - additional load equivalent to 5% body mass
Number of subjects: 14
Study: 35286196

Group type: EXPERIMENTAL
Intervention: RSV vaccine administered to pregnant mothers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36087116

Group type: EXPERIMENTAL
Intervention: Phytate group (380 mg capsule of calcium‐magnesium InsP6 every 24 h for 3 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phytate group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32302705

Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) using methylene blue as a photosensitizer activated by red and infrared diode laser
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) using red and infrared diode laser
Number of subjects: 20
Study: 33455471

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (10 weeks, 3 sessions/week)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18
Study: 34254834

Group type: EXPERIMENTAL
Intervention: Low oxalate diet (D)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Supplementation with 25 mg vitamin B6 and 400 mg magnesium oxide (S)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Combination of low oxalate diet and B6/magnesium supplementation (DS)
Number of subjects: 164
Study: 32438990

Group type: EXPERIMENTAL
Intervention: Culprit-lesion-only PCI strategy
Number of subjects: 624

Group type: COMPARATOR
Intervention: Immediate multivessel PCI strategy
Number of subjects: 624
Study: 32613224

Group type: EXPERIMENTAL
Intervention: HF-rTMS over the left DLPFC
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: HF-rTMS over the right DLPFC
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham HF-rTMS
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: HF-rTMS over the left and right DLPFC
Number of subjects: 25
Study: 33323209

Group type: EXPERIMENTAL
Intervention: American Heart Association website prompt group
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: Hourly stand prompt group
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: Cluster-specific prompts group
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: 10,000 daily step prompt group
Number of subjects: 1075
Study: 35156734

Group type: EXPERIMENTAL
Intervention: Lateralized subthalamic stimulation (unilateral 50% amplitude reduction) for ≥21 days
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (bilateral subthalamic stimulation)
Number of subjects: 22
Study: 34408569

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with house dust mite (HDM) for 24 months
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control treatment for 24 months
Number of subjects: 96
Study: 35317973

Group type: EXPERIMENTAL
Intervention: ProBio intervention (specifics not provided)
Number of subjects: 0
Study: 34189249

Group type: EXPERIMENTAL
Intervention: 70 mg/day intepirdine
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: 35 mg/day intepirdine
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study: 33087220

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Formocresol (FC)
Number of subjects: 36
Study: 33319444

Group type: EXPERIMENTAL
Intervention: 40 mg of controlled‐release morphine
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 34353073

Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Palpebral gland massage combined with a hot compress
Number of subjects: 132
Study: 33149896

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl irrigating the canals without PUI activation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl with PUI
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3% NaOCl gel irrigating the canals without PUI
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 3% NaOCl gel with PUI
Number of subjects: 40
Study: 35649241

Group type: EXPERIMENTAL
Intervention: 3.4 g psyllium fiber supplementation twice a day for 1 week before surgery
Number of subjects: 84

Group type: COMPARATOR
Intervention: No fiber supplementation before surgery
Number of subjects: 84
Study: 34245038

Group type: EXPERIMENTAL
Intervention: Diabetes Body Project (6 meetings over 6 weeks)
Number of subjects: 35
Study: 32150584

Group type: EXPERIMENTAL
Intervention: Simulation based Difficult Conversations Workshop
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 13
Study: 34514692

Group type: EXPERIMENTAL
Intervention: DAPA+SAXA+MET (10/5 mg)
Number of subjects: 382

Group type: COMPARATOR
Intervention: GLIM+MET (1-6 mg)
Number of subjects: 382
Study: 33326891

Group type: EXPERIMENTAL
Intervention: Cognitive therapy plus antidepressant medications
Number of subjects: 452

Group type: COMPARATOR
Intervention: Antidepressant medications
Number of subjects: 452
Study: 33900493

Group type: EXPERIMENTAL
Intervention: Caffeine (100 mg three times daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 32059693

Group type: EXPERIMENTAL
Intervention: Community mobilization intervention based on Socializing Evidence for Participatory Action (SEPA)
Number of subjects: 5848

Group type: COMPARATOR
Intervention: Usual dengue control practice
Number of subjects: 5848
Study: 34057996

Group type: EXPERIMENTAL
Intervention: Genetically predicted vitamin C levels (per 1 standard deviation increase)
Number of subjects: 15
Study: 35354004

Group type: EXPERIMENTAL
Intervention: Head Down Deep Breathing (HDDB)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Modified Valsalva Manoeuvre (VM)
Number of subjects: 41
Study: 36272240

Group type: EXPERIMENTAL
Intervention: Virtual Reality‐based Theory of Mind Intervention (VR‐ToMIS)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (passive‐VR)
Number of subjects: 42
Study: 32161944

Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV)
Number of subjects: 3576
Study: 34260860

Group type: EXPERIMENTAL
Intervention: Rest-pause (RP) training
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Drop-set (DS) training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Traditional resistance training (TRT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: All training groups (RP, DS, TRT)
Number of subjects: 28
Study: 33351478

Group type: EXPERIMENTAL
Intervention: PePS intervention
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 84
Study: 34676624

Group type: EXPERIMENTAL
Intervention: Active go/no-go training with sweet foods
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control go/no-go training with non-food cues
Number of subjects: 46
Study: 32493319

Group type: EXPERIMENTAL
Intervention: Digital triage tool implementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline period (no intervention)
Number of subjects: 0
Study: 35476316

Group type: EXPERIMENTAL
Intervention: Fedratinib 400 mg/day
Number of subjects: 130
Study: 33401384

Group type: EXPERIMENTAL
Intervention: Brain Breaks® video intervention for 3-5 min daily at low-to-moderate intensity for three months
Number of subjects: 704

Group type: COMPARATOR
Intervention: Normal routine (Control group)
Number of subjects: 704
Study: 32968158

Group type: EXPERIMENTAL
Intervention: Thrice-weekly 3,000 IU cholecalciferol
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Once-monthly cholecalciferol (equivalent to 9,000 IU/week)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Thrice-weekly placebo
Number of subjects: 96

Group type: COMPARATOR
Intervention: Once-monthly placebo
Number of subjects: 96
Study: 34103317

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioural therapy for insomnia (CBT‐I)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single‐session sleep hygiene (SH) education
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CBT‐I and SH education
Number of subjects: 80
Study: 32534584

Group type: EXPERIMENTAL
Intervention: Continuous infusion of methoxamine at 2 μg/kg/min
Number of subjects: 180

Group type: COMPARATOR
Intervention: Continuous infusion of normal saline (control)
Number of subjects: 180
Study: 34155568

Group type: EXPERIMENTAL
Intervention: Brivaracetam 50 mg/day
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Brivaracetam 100 mg/day
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Brivaracetam 200 mg/day
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Brivaracetam 50-200 mg/day
Number of subjects: 863

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 863

Group type: EXPERIMENTAL
Intervention: Brivaracetam (all dosages)
Number of subjects: 863
Study: 35257600

Group type: EXPERIMENTAL
Intervention: New antiretroviral drug as part of a combination antiretroviral treatment regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33788473

Group type: EXPERIMENTAL
Intervention: Process management and evaluation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional training mode
Number of subjects: 120
Study: 36117083

Group type: EXPERIMENTAL
Intervention: 3% Hydrogen Peroxide irrigation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 50
Study: 34167538

Group type: EXPERIMENTAL
Intervention: Video decision support tool (VDST) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC) group
Number of subjects: 0
Study: 32216218

Group type: EXPERIMENTAL
Intervention: HoLEP + JSSD
Number of subjects: 110

Group type: COMPARATOR
Intervention: HoLEP
Number of subjects: 110
Study: 35045185

Group type: EXPERIMENTAL
Intervention: Fosnetupitant (FosNTP) 235 mg
Number of subjects: 102

Group type: COMPARATOR
Intervention: Fosaprepitant (FosAPR) 150 mg
Number of subjects: 102
Study: 34255080

Group type: EXPERIMENTAL
Intervention: Low-fat, high-carbohydrate (LF-HC) diet
Number of subjects: 30

Group type: COMPARATOR
Intervention: High-fat, low-carbohydrate (HF-LC) diet
Number of subjects: 30
Study: 32371539

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg every 3 weeks for three cycles, followed by three adjuvant cycles, in combination with definitive radiotherapy.
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pembrolizumab and radiotherapy
Number of subjects: 29
Study: 33219482

Group type: EXPERIMENTAL
Intervention: SAM vaginal gel (intravaginal daily dose for three 28-day periods)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control (follow-up without intervention)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: SAM vaginal gel
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control
Number of subjects: 216
Study: 32400738

Group type: EXPERIMENTAL
Intervention: Group II (overweight and obese subjects)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Group II (overweight and obese subjects with metabolic syndrome)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Group I (normal-weight subjects)
Number of subjects: 111
Study: 35672894

Group type: EXPERIMENTAL
Intervention: Daily pulmonary rehabilitation training including pursed-lip breathing (PLB) training, abdominal breathing training, skeletal muscle training, and coughing and expectoration training.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Routine drug therapy, COPD knowledge education, and smoking cessation treatment (Control group).
Number of subjects: 72
Study: 34111444

Group type: EXPERIMENTAL
Intervention: Eyeglasses prescribed using standard subjective refraction (SR)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Eyeglasses prescribed using autorefraction (AR)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Comparison of spherical equivalents using SR and AR
Number of subjects: 400
Study: 35772224

Group type: EXPERIMENTAL
Intervention: Vertical one-handed chest compression (Test 2)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional one-handed chest compression (Test 1)
Number of subjects: 42
Study: 34176245

Group type: EXPERIMENTAL
Intervention: Suubi + Adherence intervention (n = 358)
Number of subjects: 702

Group type: COMPARATOR
Intervention: Bolstered standard of care (BSOC; n = 344)
Number of subjects: 702
Study: 33207743

Group type: EXPERIMENTAL
Intervention: MCT/ω‐3 PUFA‐enriched IVFE
Number of subjects: 92

Group type: COMPARATOR
Intervention: Soybean oil-based IVFE
Number of subjects: 92
Study: 35443373

Group type: EXPERIMENTAL
Intervention: FDC of Remogliflozin 100mg + Vildagliptin 50mg (RV)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Empagliflozin 25mg + Linagliptin 5mg (EL)
Number of subjects: 400
Study: 34574483

Group type: EXPERIMENTAL
Intervention: Hypoglycemia problem-solving program (HPSP), 8-week duration, 90 min weekly sessions
Number of subjects: 71

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Hypoglycemia problem-solving program (HPSP)
Number of subjects: 71
Study: 36047028

Group type: EXPERIMENTAL
Intervention: Durasul highly cross‐linked polyethylene
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sulene polyethylene
Number of subjects: 90
Study: 32981401

Group type: EXPERIMENTAL
Intervention: Kinect video game training (KVG)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional training (CT)
Number of subjects: 10
Study: 32913632

Group type: EXPERIMENTAL
Intervention: Formal ether concentration method
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Wet preparation method
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Saturated sugar flotation method
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Overall infection rate
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Age group 12-14 years
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Age group 9-11 years
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Age group 6-8 years
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Single parasite infection
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Multiple parasite infection
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Taenia spp.
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Giardia lamblia
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Schistosoma mansoni
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Ascaris lumbricoides
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Entamoeba coli
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Hymenolepis nana
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Entamoeba histolytica
Number of subjects: 134
Study: 32574094

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy (ESWT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 60